Breaking News
May 3, 2019 - Vaping and Smoking May Signal Greater Motivation to Quit
May 3, 2019 - Dementia looks different in brains of Hispanics
May 3, 2019 - Short-Staffed Nursing Homes See Drop In Medicare Ratings
May 3, 2019 - Study of teens with eating disorders explores how substance users differ from non-substance users
May 3, 2019 - Scientists develop new video game that may help in the study of Alzheimer’s
May 3, 2019 - Arc Bio introduces Galileo Pathogen Solution product line at ASM Clinical Virology Symposium
May 3, 2019 - Cornell University study uncovers relationship between starch digestion gene and gut bacteria
May 3, 2019 - How to Safely Use Glucose Meters and Test Strips for Diabetes
May 3, 2019 - Anti-inflammatory drugs ineffective for prevention of Alzheimer’s disease
May 3, 2019 - Study tracks Pennsylvania’s oil and gas waste-disposal practices
May 3, 2019 - Creating a better radiation diagnostic test for astronauts
May 3, 2019 - Vegans are often deficient in these four nutrients
May 3, 2019 - PPDC announces seed grants to develop medical devices for children
May 3, 2019 - Study maps out the frequency and impact of water polo head injuries
May 3, 2019 - Research on Reddit identifies risks associated with unproven treatments for opioid addiction
May 3, 2019 - Good smells may help ease tobacco cravings
May 3, 2019 - Medical financial hardship found to be very common among people in the United States
May 3, 2019 - Researchers develop multimodal system for personalized post-stroke rehabilitation
May 3, 2019 - Study shows significant mortality benefit with CABG over percutaneous coronary intervention
May 3, 2019 - Will gene-editing of human embryos ever be justifiable?
May 3, 2019 - FDA Approves Dengvaxia (dengue vaccine) for the Prevention of Dengue Disease in Endemic Regions
May 3, 2019 - Why Tonsillitis Keeps Coming Back
May 3, 2019 - Fighting the opioid epidemic with data
May 3, 2019 - Maggot sausages may soon be a reality
May 3, 2019 - Deletion of ATDC gene prevents development of pancreatic cancer in mice
May 2, 2019 - Targeted Therapy Promising for Rare Hematologic Cancer
May 2, 2019 - Alzheimer’s disease is a ‘double-prion disorder,’ study shows
May 2, 2019 - Reservoir bugs: How one bacterial menace makes its home in the human stomach
May 2, 2019 - Clinical, Admin Staff From Cardiology Get Sneak Peek at Epic
May 2, 2019 - Depression increases hospital use and mortality in children
May 2, 2019 - Vicon and NOC support CURE International to create first gait lab in Ethiopia
May 2, 2019 - Researchers use 3D printer to make paper organs
May 2, 2019 - Viral infection in utero associated with behavioral abnormalities in offspring
May 2, 2019 - U.S. Teen Opioid Deaths Soaring
May 2, 2019 - Opioid distribution data should be public
May 2, 2019 - In the Spotlight: “I’m learning every single day”
May 2, 2019 - 2019 Schaefer Scholars Announced
May 2, 2019 - Podcast: KHN’s ‘What The Health?’ Bye-Bye, ACA, And Hello ‘Medicare-For-All’?
May 2, 2019 - Study describes new viral molecular evasion mechanism used by cytomegalovirus
May 2, 2019 - SLU study suggests a more equitable way for Medicare reimbursement
May 2, 2019 - Scientists discover first gene involved in lower urinary tract obstruction
May 2, 2019 - Researchers identify 34 genes associated with increased risk of ovarian cancer
May 2, 2019 - Many low-income infants receive formula in the first few days of life, finds study
May 2, 2019 - Global study finds high success rate for hip and knee replacements
May 2, 2019 - Taking depression seriously: What is it?
May 2, 2019 - With Head Injuries Mounting, Will Cities Put Their Feet Down On E-Scooters?
May 2, 2019 - Scientists develop small fluorophores for tracking metabolites in living cells
May 2, 2019 - Study casts new light into how mothers’ and babies’ genes influence birth weight
May 2, 2019 - Researchers uncover new brain mechanisms regulating body weight
May 2, 2019 - Organ-on-chip systems offered to Asia-Pacific regions by Sydney’s AXT
May 2, 2019 - Adoption of new rules drops readmission penalties against safety net hospitals
May 2, 2019 - Kids and teens who consume zero-calorie sweetened beverages do not save calories
May 2, 2019 - Improved procedure for cancer-related erectile dysfunction
May 2, 2019 - Hormone may improve social behavior in autism
May 2, 2019 - Alzheimer’s disease may be caused by infectious proteins called prions
May 2, 2019 - Even Doctors Can’t Navigate Our ‘Broken Health Care System’
May 2, 2019 - Study looks at the impact on criminal persistence of head injuries
May 2, 2019 - Honey ‘as high in sugars as table sugar’
May 2, 2019 - Innovations to U.S. food system could help consumers in choosing healthy foods
May 2, 2019 - FDA Approves Mavyret (glecaprevir and pibrentasvir) as First Treatment for All Genotypes of Hepatitis C in Pediatric Patients
May 2, 2019 - Women underreport prevalence and intensity of their own snoring
May 2, 2019 - Concussion summit focuses on science behind brain injury
May 2, 2019 - Booker’s Argument For Environmental Justice Stays Within The Lines
May 2, 2019 - Cornell research explains increased metastatic cancer risk in diabetics
May 2, 2019 - Mount Sinai study provides fresh insights into cellular pathways that cause cancer
May 2, 2019 - Researchers to study link between prenatal pesticide exposures and childhood ADHD
May 2, 2019 - CoGEN Congress 2019: Speakers’ overviews
May 2, 2019 - A new strategy for managing diabetic macular edema in people with good vision
May 2, 2019 - Sagent Pharmaceuticals Issues Voluntary Nationwide Recall of Ketorolac Tromethamine Injection, USP, 60mg/2mL (30mg per mL) Due to Lack of Sterility Assurance
May 2, 2019 - Screen time associated with behavioral problems in preschoolers
May 2, 2019 - Hormone reduces social impairment in kids with autism | News Center
May 2, 2019 - Researchers synthesize peroxidase-mimicking nanozyme with low cost and superior catalytic activity
May 2, 2019 - Study results of a potential drug to treat Type 2 diabetes in children announced
May 2, 2019 - Multigene test helps doctors to make effective treatment decisions for breast cancer patients
May 2, 2019 - UNC School of Medicine initiative providing unique care to dementia patients
May 2, 2019 - Nestlé Health Science and VHP join forces to launch innovative COPES program for cancer patients
May 2, 2019 - Study examines how our brain generates consciousness and loses it during anesthesia
May 2, 2019 - Transition Support Program May Aid Young Adults With Type 1 Diabetes
May 2, 2019 - Study shows how neutrophils exacerbate atherosclerosis by inducing smooth muscle-cell death
May 2, 2019 - Research reveals complexity of how we make decisions
Making Laboratories More Efficient with the Most Modern LIMS on the Market

Making Laboratories More Efficient with the Most Modern LIMS on the Market

Please tell us about LabVantage and the work that you do?

LabVantage is a leader in providing laboratory information management systems and electronic laboratory notebooks to a very broad range of industries and laboratory types. We have been doing this now for over 35+ years. We have close to 1,500 customers that we deliver solutions to with our platform, LabVantage LIMS.

What are the benefits and features of the new LabVantage 8.4 LIMS?

Each year we come out with a new release of our product that has evolved and expanded in its capabilities. We have added some new functionality to the platform to be able to address certain customer needs based on their feedback.

The big improvement in 8.4 is our new Work Assignment and Resource Planning module, which helps with lab efficiency and productivity. It allows laboratory managers to see current and upcoming scheduled work and make assignments based on the availability of individuals and user groups according to their corporate calendars and lab resources. It also displays the calendar availability, existing work assignments, work capacity, and the certification status of the facility’s instruments. Testing master data can be configured to identify preferred laboratory instruments and users so that incoming work can be quickly assigned and optimized. The features in the module include many options and are designed for maximum flexibility and ease of use

Tell us how the LabVantage 8.4 LIMS meets the newest FDA guidelines?

The FDA and other agencies have been very pro-active in publishing new standards for data integrity and compliance. Over 60% of the LabVantage user base is regulated by one government agency or another, and so we cater to that very closely.

When new guidelines come out, LabVantage usually reacts before they become regulation. We get a lot of feedback from our pharma and life science customers to let us know what they need ahead of time, and to make sure everything is compliant.

One of those areas has to do with data integrity. The guidance that came from the FDA had some new indications of compliance that were necessary for computer systems like ours. We enhanced our product to be able to adhere to those regulations when they came out.

This was particularly in the areas of data entry and data integrity, and temporary memory – entering results that have not been committed to the database yet. It allows us to be able to manage and audit things in order to be compliant even before we commit to the database.

With markets such as the food and beverage, oil and gas, and chemical process manufacturing, how does the new update and the new product help regulate them?

Each of those industries has a different regulation. The most strict industry tends to be pharmaceuticals, and food and beverage companies, because they are now under a variety of different food safety acts. The system obviously has some security controls, audit trails, version controlling and data integrity capabilities, to make sure that they are fully compliant.

In other areas like oil and gas, although they are not regulated to the same rigor as food and beverage, they do want to run good laboratory practices. Those capabilities are built into the system already.

Can you tell us about the other applications that will benefit?

As I mentioned, we do a lot of work in the pharmaceutical industry. We have built what are called Project Accelerators. These are pre-packaged solutions that are geared towards specific laboratory industries and types.

One of them is called LabVantage Pharma for the pharma industry. We provide a pre-validated and pre-configured solution for that industry, which is unique. No other vendor does that. We also cater to biobanks (biorepository specimen management banks), and the diagnostics base (clinical and molecular diagnostic labs). And for general manufacturing that is non-pharmaceutical, we have a quality solution for them.

We also have an oil and gas accelerator for refining manufacturing and chemical manufacturing.

Image Credit:Shutterstock/Microgen

Could you tell me really what sets your product apart? How does it compare to others in the market?

We are unique in our technology. LabVantage is one of the only vendors that supplies and provides access to the system through a browser. There is no client to install on your desktop, tablet or workstation. If you have a browser, you have access to the system.

We also fully support portable computing technologies. LabVantage has also now fully embraced cloud technology for hosting of the system. Servers can be in-house or out in the cloud if necessary.

What is in store for the future? What can we expect to see?

As I mentioned, we do meet with a large body of our customer base every year. This is an opportunity for them to voice their needs and concerns or desires.

One of the areas that we are going to be focusing on very heavily is a new solution for scientific data management. All the raw data that the instruments are generating typically stays on the PC that generated them. We are going to gather up that data, put it into a database, protect and index it, and make it accessible.

About Labvantage

LabVantage Solutions, Inc. is the leading global laboratory informatics provider. Our industry-leading LIMS and ELN  solution and world-class services are the result of 35+ years of experience in laboratory informatics. LabVantage offers a comprehensive portfolio of products and services that enable companies to innovate faster in the R&D cycle, improve manufactured product quality, achieve accurate recordkeeping and comply with regulatory requirements.

LabVantage is a highly configurable, web-based LIMS/ELN that powers hundreds of laboratories globally, large and small. Built on a platform that is widely recognized as the best in the industry, LabVantage can support hundreds of concurrent users as well as interface with instruments and other enterprise systems. It is the best choice for industries ranging from pharmaceuticals and consumer goods to molecular diagnostics and bio banking. LabVantage domain experts advise customers on best practices and maximize their ROIs by optimizing LIMS implementation with a rapid and successful deployment.

Tagged with:

About author

Related Articles